Merck said it would buy Schering-Plough for $41.1 billion in a cash and stock deal.
Love him or hate him, here are the medical facts: the arthroscopic surgery A-Rod underwent repaired only the labrum tear, so rehab will be shortened and he won't miss the entire season.
Under the Federal Deposit Insurance Corporation's Temporary Liquidity Guarantee Program, companies can sell their debt insured by the full faith and credit of the United States, in exchange for paying a fee to FDIC.
In a long-awaited victory for patients injured by pharmaceuticals, the Supreme Court ruled 6-3 on Wednesday that a drug company is not immune from injury claims in state court simply because the FDA has approved a product and its labeling.
The lawsuit, filed Tuesday in U.S. District Court in Manhattan, alleges CEO Jeffrey Immelt and other top management misled investors by cutting the dividend after promising to maintain it, causing holders to buy shares at inflated prices.
A Congressional bill, screening Abdominal Aortic Aneurysms Very Efficiently, was introduced on February 26, 2009 by Reps. Gene Green (D-TX) and John Shimkus (R-IL). The orphan disease affecting about 250,000 continues to require Medical coverage, the group says.
A history of major depression increases the risk of heart disease over and above any genetic risks common to depression and heart disease, according to researchers at Washington University School of Medicine in St. Louis and the VA.
The Senate is pitched for battle, having heard the details of President Obama's plans for health care reform. DOTmed News puts the Federal budget proposal in perspective.
Genentech pushed up the date of its annual meeting so it could speak to holders before Roche's tender offer expires on March 12.
Ratings agencies eye the company for a possible downgrade.
Glas, who made the DOTmed 100 list again this year and is also DOTmed Certified, says when things are difficult in one area, he turns to another.
A Genentech special committee unanimously voted to decline Roche's $43.7 billion ($86.50 a share) takeover offer and urged shareholders to do the same.
A key advantage of inhaled anesthetics over intravenous sedation, which is the current approach in the ICU, is that inhaled anesthesia delivers and clears sedatives by way of the lungs, bypassing the metabolic and excretory systems.
Study seeks to find alternative to standard of care for women with undiagnosed chest pain.
Endocrinologists and ultrasound experts have been working together to improve the quality of ultrasound-guided invasive procedures of the thyroid and parathyroid glands, which use neck ultrasound.
The purchases will catapult Medtronic into this fast-growing, sought-after market, while pitting it against Edwards Lifesciences, now locked in patent litigation with CoreValve. Read a DOTmed exclusive report.
During his third term in 1990, he was caught in an FBI sting and videotaped in a hotel room smoking crack. He served six months in jail.
After seeing the great success of his patients, Dr. Smith chose the LAP-BAND device for himself. In 2004, he opened Fort Worth LAP-BAND, a private practice dedicated to the treatment of morbid obesity.
A study looking at over 21,000 patients from 11 health centers found that patients who received mailed reminders for scheduling colorectal cancer screenings were more likely to comply than those patients who didn't get reminders in the mail.
The purpose is to fund the 44 percent of Genentech it doesn't already own.
Recent quarters have been tumultuous: The company's shares plunged 56 percent last year; GE's stock dropped from highs of $38.52 in April to lows of $10.66 earlier this month.
Cardiovascular and Neuromodulation posted double-digit growth. If not for a low dollar, diabetes and surgical would have reported double-digit earnings, too.
The technology will allow early prediction of bone disorders such as osteoporosis and acceleration of fracture healing.
The rare eye condition, called sympathetic ophthalmia, occurs when vision is lost in one eye through injury or multiple surgeries, and the body's overactive immune system attacks the healthy eye, leaving untreated patients blind.
The combined company will offer a broad portfolio of devices to improve therapies for heart failure.
For women with diagnosed breast cancer, MRI provides enhanced detection in both the breast known to have cancer and the opposite, contralateral, breast.
He was best known for the Jarvik 7 artificial heart.
CMS to issue final decision after comment period; the American Cancer Society is in favor of CTC and says it is cost-effective.
Researchers at Washington University School of Medicine in St. Louis and Harvard University analyzed several decades worth of data and found that people who exercised the most were 24 percent less likely to develop the colon cancer than those who exercised the least.
Chocolate and cocaine are activated by the same circuitry as falling in love.
Large-scale USC and Mayo Clinic study is the first to link a commercially available software program to improvement on unaffiliated standard measures of memory and to better performance on everyday tasks.
Roche made good on its promise to launch a hostile $86.50 a share offer for the 44 percent of Genentech it doesn't already own.
The small cap medical OEM is defying the market with solid performance for its left-ventricular assist device. A DOTmed exclusive report.
As a large loaner, Wall Street fears that keeping the payout may cause the company to lose its Triple A debt rating. An update on the company's financials.
Catering to India's growing appetite for state-of-the art scanners, GE will manufacture India's first digital flat panel based X-ray system, Tejas DR-F, at a 40 percent lower cost than imported systems of its kind.
The Russian market is expected to provide an attractive growth opportunity for foreign manufacturers, according to a Global Research & Data Services report.
The Neurotech Industry Investing & Partnering Conference 2009 will take place at the St. Regis Hotel in San Francisco May 11-13. The conference will highlight innovations in devices, drugs and diagnostics for the brain and nervous system.
At the new price, Roche's buyout is valued at $42 billion, down from the original $44 billion bid.
Hitachi told DOTmed News that the company does not report medical earnings separately.
Small medical device companies are at bargain prices and make tempting takeover targets for cash-rich companies, NextWave analyst John Putnam tells DOTmed News. However, elective procedure products may suffer in today's recession.
While a one-time item caused earnings to plunge, Siemens fared better than its rivals, GE and Philips.
Mortality and complications dropped and hospitals saved money when patient data was stored on computers, rather than on paper forms and handwritten notes, a Johns Hopkins study has found.
Geron, a California-based biotech company, will see if embryonic stem cells can trigger the growth of new nerve cells in patients with spinal cord injuries.
Special cooling therapy reduces chances of brain damage, increases chances of survival.
The Materials Information Society: A call for papers has been issued for the event, to be held Aug. 10-12, 2009 in Minneapolis.
General Electric Company, ending one of the worst years in the company's 117-year history, posted a 44 percent drop in fourth quarter earnings.
A range of robotic devices can guide a camera for surgeons performing gallbladder surgery, according to a study conducted at the Royal Free Hospital in London.
Researchers are re-designing bio-hybrid devices that promote vascularization and effective nutrient delivery to prevent islet cell necrosis.
While J&J's earnings climbed in the quarter ended in December, J&J says earnings will fall short of analysts' expectations for 2009.
In a longstanding battle, a Federal Circuit Court judge in Washington, D.C., reversed a 2005 jury decision finding that a J&J stent infringed on Boston Scientific's patent.